Status:
COMPLETED
Effect of Prevalence of BMI on Efficacy of Herbal Medicines in Girls' Sexual Precocity
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Precocious Puberty
Eligibility:
FEMALE
4-8 years
Brief Summary
Effect of Prevalence of Overweight and Obesity(Body Mass Index (BMI)) on Efficacy of herbal medicines(ZiYinXieHuo) in girls sexual Precocity
Detailed Description
Herbal medicines(ZiYinXieHuo) might have implications for the effects of treatment. in sexual Precocity among the higher BMI girls. Thus the investigator use cohort studies to confirm this hypothesis....
Eligibility Criteria
Inclusion
- \- no abnormal weight and height in parents and families, no organic diseases, no drugs affecting gonadal axis or obesity; normal health, no secondary obesity caused by endocrine and genetic metabolic diseases, no lifestyle intervention to treat obesity.
Exclusion
- \- central neoplastic lesions, rare syndrome, severe heart, liver and kidney diseases and other chronic diseases such as tuberculosis, asthma, rheumatism, complicated infection, congenital hypothyroidism associated with precocious puberty, peripheral precocious puberty, incomplete precocious puberty and so on.
Key Trial Info
Start Date :
December 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 4 2023
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT04665713
Start Date
December 18 2020
End Date
July 4 2023
Last Update
July 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Fudan University
Shanghai, China, 201102